Prostate Cancer

Clinical trials show promise for prostate cancer drug

A 30 percent reduction in mortality risk is one of the impressive results achieved in a global clinical drug trial for the treatment of prostate cancer. The full trial data are due to be presented today at one of the world´s ...

Jan 30, 2014
popularity not rated yet | comments 0

Mechanism affecting risk of prostate cancer is found

A research group at Biocenter Oulu in Finland has identified a mechanism related to a transcription factor that binds much more strongly onto a particular SNP variant, thereby initiating a genetic programme which enhances ...

Jan 10, 2014
popularity 3.7 / 5 (3) | comments 0

Enzalutamide in prostate cancer: Hints of added benefit

Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic ...

Dec 06, 2013
popularity not rated yet | comments 0

World first trial to improve prostate cancer care

Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.

Nov 28, 2013
popularity not rated yet | comments 0

Latest Spotlight News